Back
Flex Vs. Lyra Therapeutics Industry Stock Comparison
Buy
76
FLEX
Flex
Last Price:
$51.29
Seasonality Move:
8.65%
Sell
32
LYRA
Lyra Therapeutics
Last Price:
$9.20
Seasonality Move:
-2.29%
Sell
32
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FLEX Stock Price Chart
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $9.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
FLEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.09 | Buy |
Relative Strength Index (14 RSI): | 75.16 | Buy |
Chaikin Money Flow: | -831427 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.18 - 49.64) | Buy |
Bollinger Bands (100): | (33.13 - 44.97) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 44.26 | Sell |
Chaikin Money Flow: | -16263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
FLEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.44 | Buy |
20-day SMA: | 47.31 | Buy |
50-day SMA: | 42.91 | Buy |
200-day SMA: | 38.33 | Buy |
8-day EMA: | 11.39 | Buy |
20-day EMA: | 4.88 | Buy |
50-day EMA: | 2.01 | Buy |
200-day EMA: | 0.51 | Buy |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.48 | Sell |
20-day SMA: | 12.91 | Sell |
50-day SMA: | 9.32 | Sell |
200-day SMA: | 9.78 | Sell |
8-day EMA: | 10.03 | Sell |
20-day EMA: | 11.05 | Sell |
50-day EMA: | 10.19 | Sell |
200-day EMA: | 21.81 | Sell |
Flex Earnings Growth & FLEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.49 per share, and an increase next year of $0.34 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Flex Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |